Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1997 Nov;110(2):270–276. doi: 10.1111/j.1365-2249.1997.tb08327.x

Studies of epitope restriction on myeloperoxidase (MPO), an important antigen in systemic vasculitis

A K SHORT *, C M LOCKWOOD *
PMCID: PMC2265509  PMID: 9367412

Abstract

Anti-neutrophil cytoplasmic antibodies are important components of the inflammatory response in patients with systemic vasculitis. Their role in the pathogenesis of these conditions remains incompletely defined. Several antigens have been identified, and MPO is one of the most important. To gain more understanding of the immune mechanisms involved, we were keen to see if the antibody response to MPO was restricted, or whether there was a general loss of tolerance to the whole surface of the molecule. To study the epitopes we employed both ELISA and biosensor technology, and were able to demonstrate restriction both in the number and localization of the epitopes being recognized.

Keywords: epitope mapping, myeloperoxidase, vasculitis, biosensor

Full Text

The Full Text of this article is available as a PDF (724.6 KB).

References

  • 1.Falk RJ, Jennette JC. Antineutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotising and crescentic glomerulonephritis. N Engl J Med. 1988;318:1651–7. doi: 10.1056/NEJM198806233182504. [DOI] [PubMed] [Google Scholar]
  • 2.Van der Woude FJ, Lobatto S, Permin H, et al. Autoantibodies against neutrophils and monocytes: tools for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet. 1985;i:425–9. doi: 10.1016/s0140-6736(85)91147-x. [DOI] [PubMed] [Google Scholar]
  • 3.Cohen Tervaert JW, Huitema MG, Hene RJ, et al. Prevention of relapses in Wegener's granulomatosis by treatment based on anti-neutrophil cytoplasmic antibody titre. Lancet. 1990;ii:709–11. doi: 10.1016/0140-6736(90)92205-v. [DOI] [PubMed] [Google Scholar]
  • 4.Falk RJ, Terrell RS, Charles LA, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA. 1990;87:4115–9. doi: 10.1073/pnas.87.11.4115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Van der Wiel BA, Dolman KM, van der Meer-Gerritsen CH, et al. Interference of Wegener's granulomatosis autoantibodies with neutrophil proteinase 3 activity. Clin Exp Immunol. 1992;90:409–14. doi: 10.1111/j.1365-2249.1992.tb05860.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Pinching AJ, Rees AJ, Pussell BA, et al. Relapses in Wegener's granulomatosis: the role of infection. Br Med J. 1980;281:836–8. doi: 10.1136/bmj.281.6244.836. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Nassberger L, Johansson A-C, Bjorck S, Sjoholm AG. Antibodies to neutrophil granulocyte myeloperoxidase and elastase: autoimmune responses in glomerulonephritis due to hydralazine treatment. J Intern Med. 1991;229:261–5. doi: 10.1111/j.1365-2796.1991.tb00342.x. [DOI] [PubMed] [Google Scholar]
  • 8.Jayne DRW, Lockwood CM. New approaches to therapy in systemic vasculitis. J Roy Soc Med. 1990;83:407–10. [Google Scholar]
  • 9.Falk RJ, Becker M, Terrell R, Jennette JC. Anti-myeloperoxidase antibodies react with native but not denatured myeloperoxidase. Clin Exp Immunol. 1992;89:274–8. doi: 10.1111/j.1365-2249.1992.tb06944.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Friguet B, Djavadi-Ohaniance L, Pages J, et al. A conventional enzyme-linked immunosorbent assay for testing whether monoclonal antibodies recognise the same antigenic site. Application to hybridomas specific for the β2-subunit of Escherichia coli tryptophan synthase. J Immunol Methods. 1983;60:351–8. doi: 10.1016/0022-1759(83)90292-2. [DOI] [PubMed] [Google Scholar]
  • 11.Jönsson U, Fagerstam L, Ivarsson B, et al. Real time biospecific interaction analysis using surface plasmon resonance and a sensor chip technology. Biotechniques. 1991;11:620–7. [PubMed] [Google Scholar]
  • 12.Fägerstam LG, Frostell A, Karlsson R, et al. Detection of antibody antigen interactions by surface plasmon resonance. Application to epitope mapping. J Mol Recog. 1990;3:208–14. doi: 10.1002/jmr.300030507. [DOI] [PubMed] [Google Scholar]
  • 13.Andrews PC, Krinsky NI. Human myeloperoxidase and hemi-myeloperoxidase. Methods Enzymol. 1986;132:369–78. doi: 10.1016/s0076-6879(86)32022-6. [DOI] [PubMed] [Google Scholar]
  • 14.Short AK, Lockwood CM, Bollen A, Moguilevsky N. Neutrophil and recombinant myeloperoxidase as antigens in ANCA positive systemic vasculitis. Clin Exp Immunol. 1995;102:106–11. doi: 10.1111/j.1365-2249.1995.tb06643.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Short AK, Lockwood CM. Antigen specificity in hydralazine associated ANCA positive systemic vasculitis. QJM. 1995;88:775–83. [PubMed] [Google Scholar]
  • 16.Bowman C, Lockwood CM. Clinical applications of a radioimmunoassay for autoantibodies to glomerular basement membrane. J Clin Lab Immunol. 1985;17:197–202. [PubMed] [Google Scholar]
  • 17.Schneider C. Affinity of different Moabs to prostate specific antigen and its complex with alpha- 1-antichymotrypsin. Abstract at the third European BIA symposium. London. 1993;12 [Google Scholar]
  • 18.Jonsson U, Fagerstam L, Ivarsson B, et al. Real time biospecific interaction analysis using surface plasmon resonance and a sensor chip technology. Biotechniques. 1991;11:620–7. [PubMed] [Google Scholar]
  • 19.Geysen HM, Rodda SJ, Mason TJ, et al. Strategies for epitope analysis using peptide synthesis. J Immunol Methods. 1987;102:259–74. doi: 10.1016/0022-1759(87)90085-8. [DOI] [PubMed] [Google Scholar]
  • 20.Malthiery Y, Henry M, Zanelli E. Epitope mapping of human thyroglobulin reveals an immunodominant region. FEBS. 1991;279:190–2. doi: 10.1016/0014-5793(91)80146-t. [DOI] [PubMed] [Google Scholar]
  • 21.Williams RC, Jnr, Staud R, Malone CC, et al. Epitopes on proteinase-3 recognised by antibodies from patients with Wegener's granulomatosis. J Immunol. 1994;152:4722–37. [PubMed] [Google Scholar]
  • 22.Finke R, Seto P, Ruf J, et al. Determination at the molecular level of a B cell epitope on thyroid peroxidase likely to be associated with autoimmune thyroid disease. J Clin Endocrinol Metab. 1991;73:919–21. doi: 10.1210/jcem-73-4-919. [DOI] [PubMed] [Google Scholar]
  • 23.Libert F, Ludgate M, Dinsart C, Vassart G. Thyroperoxidase, but not the thyrotropin receptor, contains sequential epitopes recognised by autoantibodies in recombinant peptides expressed in the pUEX vector. J Clin Endocrinol Metab. 1991;73:857–60. doi: 10.1210/jcem-73-4-857. [DOI] [PubMed] [Google Scholar]
  • 24.Amit AG, Mariuzza RA, Phillips SEV, Poljak RJ. Three dimensional structure of an antigen-antibody complex at 2–8A resolution. Science. 1986;233:747–53. doi: 10.1126/science.2426778. [DOI] [PubMed] [Google Scholar]
  • 25.Sheriff S, Silverton EW, Padlan EA, et al. Three dimensional structure of an antibody-antigen complex. Proc Natl Acad Sci USA. 1987;84:8075–9. doi: 10.1073/pnas.84.22.8075. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Tulip WR, Varghese JN, Webster RG, et al. Crystal structures of neuraminidase-antibody complexes. Cold Spring Harbour Symp Quant Biol. 1990;54:257–63. doi: 10.1101/sqb.1989.054.01.032. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES